mHealth for Early Psychosis Caregivers in Statewide Program Outreach

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Caregiver; Caregiver Distress; Caregiver to a Young Adult With Early Psychosis; Family Caregivers Interventions: Behavioral: Bolster Sponsors: University of North Carolina, Chapel Hill; North Carolina Department of Health and Human Services Not yet...

A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Acute Pain Interventions: Drug: Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion) Sponsors: AFT Pharmaceuticals, Ltd. Not yet recruiting Conditions: Acute Pain Interventions:...

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) – Relapsing-remitting Interventions: Drug: Ublituximab Sponsors: Northwestern University; TG Therapeutics, Inc. Not yet recruiting Conditions: Multiple Sclerosis; Multiple Sclerosis (MS) –...

Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Spinal Cord Injury Cervical; Spinal Cord Injuries (Complete and Incomplete) Interventions: Device: Brain Computer Interface (BCI) – Functional Electrical Stimulation (FES) system Sponsors: Case Western Reserve University; University Hospitals...

A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy

by palligoelme@gmail.com | Nov 6, 2025 | Clinical Trials

​ Conditions: Overweight; Obesity Interventions: Drug: LY4167586; Drug: Placebo; Drug: LY4167586 Sponsors: Eli Lilly and Company Not yet recruiting Conditions: Overweight; Obesity Interventions: Drug: LY4167586; Drug: Placebo; Drug: LY4167586 Sponsors: Eli Lilly and...